Displaying items by tag: department of medicine

UAB’s Seth Landefeld joins the Board of Directors of the American Board of Internal Medicine.
Vaccines are scientifically proven to save lives and prevent major outbreaks of highly infectious diseases among large populations in a safe and effective way.
The five-year grant from the NHLBI to the labs of Jennifer and David Pollock also includes a third project at the University of Utah, bringing together three highly successful research entities.
The grant will initially fund two fellowship positions for postdoctoral fellows (basic or clinical) wishing to train in the area of heart failure research.
The Rheumatology Research Foundation’s Journey to Cure campaign funds eight rheumatology opportunities at the University of Alabama at Birmingham.

Unusual case of teen patient diagnosed with colorectal cancer receives innovative first-in-human clinical trial at UAB, reflecting a unique story of cancer and hope.

A longtime UAB physician, educator and administrator has been honored with a major award from the Society for General Internal Medicine.
The findings suggest targeting specific T-cell subsets may be a therapeutic approach to prevent heart failure after a heart attack.
Tuberculosis kills 1.8 million people a year, and 10 million more are infected. Development of host-cell directed therapies that could restore cellular function during M. tuberculosis infection, such as a “release and kill” strategy, could shorten drug treatment of TB patients.
Abnormal antibody production that allows inflammation leading to AIDS is detected by analysis of antibodies in gut fluid of HIV-1-infected people.
In another example of precision medicine, UAB researchers have used IPF patients own lung tissue to create models to determine the most effective medication for that patient.
A Western-style diet, with more omega-6 fatty acids than the Mediterranean, dysregulates lipid signaling in aged mice and promotes inflammation.
John D. Mountz, M.D., Ph.D., and Jasvinder A. Singh, M.D., have been awarded prestigious rheumatology awards for advances in basic and clinical research.
Antibody VRC01 proves safe for individuals infected with HIV-1 but only modestly controls the virus in participants who stop receiving antiretroviral therapy.

Becker’s Hospital Review ranks the UAB Comprehensive Cancer Center as one of 100 Hospitals and Health Systems with great oncology programs in America. 

Page 29 of 36